Monodisperse polyethylene glycols-modified (M-PEGylated) biomaterials exhibit high structural accuracy, biocompatibility, and fine-tunable physicochemical properties. To develop "smart" drug delivery systems in a controllable and convenient manner, a peptidic M-PEG "comb" with fluorinated L-lysine side chains and a fluorescent N-terminal is conveniently prepared as a F magnetic resonance imaging ( F MRI) and fluorescence dual-imaging traceable and thermo-responsive "add-on" module for liposomal theranostics in cancer therapy. The peptidic M-PEG "comb" has high biocompatibility, thermo-responsivity with a sharp lower critical solution temperature, an aggregation-induced emission fluorescence, and high F MRI sensitivity. As a highly branched amphiphile, it self-assembles and firmly anchors on the doxorubicin-loaded liposomal nanoparticles, which M-PEGylates the liposomes and facilitates the thermo-responsive drug release and drug tracking with dual-imaging technologies. In a rodent xenograft model of human liver cancer HepG2 cells, the M-PEGylated liposomes exhibit long in vivo half time, low toxicity, high tumor accumulation, "hot spot" F MRI, and therapeutic efficacy. With accurately programmable chemical structure, fine-tunable physicochemical and biological properties to meet the demands of diagnosis, drug delivery, and therapy, the M-PEG "comb" is promising as a versatile "add-on" module for rapid and convenient formulation of various "smart" theranostics.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/adhm.201901331 | DOI Listing |
ACS Appl Mater Interfaces
December 2024
Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences-Wuhan National Laboratory for Optoelectronics, Wuhan 430071, China.
Imaging-guided chemo-photothermal combination therapy (chemo-PTT) is recognized for its synergistic therapeutic effects, reduced side effects, and minimal drug resistance, while the development of such theranostics has been hampered by poor imaging and therapy performance and tedious formulation. Herein, we introduce an all-in-one "add-on" module () for the convenient construction of doxorubicin (DOX)-loaded nanoparticles (DOX@BBT) and efficient second near-infrared (NIR-II) fluorescence imaging (FLI)-guided synergistic chemo-PTT of drug-resistant lung cancer. The delicate Janus amphiphilic structure of enables multifunctionality, including NIR-II FLI, aggregation-induced emission (AIE) characteristics, moderate photothermal conversion efficiency (PCE), excellent photostability, and polyethylene glycolation (PEGylation), which could improve the NIR-II FLI and PTT performance, relieve the complexity in theranostics, and enable high reproducibility of the multifunctional theranostics.
View Article and Find Full Text PDFInt J Environ Res Public Health
October 2024
Institute for Infectious Diseases and Infection Control, Jena University Hospital, 07747 Jena, Germany.
Healthcare professionals are particularly vulnerable to mental health issues during epidemics, as evidenced by the COVID-19 crisis. German public health authorities, crucial for disease prevention, faced significant strain from chronic understaffing and resource limitations exacerbated by the pandemic. The study was designed as a cross-sectional, observational online survey.
View Article and Find Full Text PDFInt J Environ Res Public Health
August 2024
Department of Psychology, MSB Medical School Berlin, 14197 Berlin, Germany.
Traumatic experiences and maltreatment are highly prevalent among adolescents in foster or institutional care and have severe long-term effects on mental health. Childhood maltreatment increases the risk of revictimization. This study aimed to evaluate the efficacy of the internet-based prevention program EMPOWER YOUTH in reducing victimization experiences among youth with care experience.
View Article and Find Full Text PDFAsian J Psychiatr
September 2024
Department of Biostatistics, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India. Electronic address:
Background: The standard treatments for Obsessive Compulsive Disorder (OCD) have been pharmacological and psychotherapeutic, with preliminary evidence for yoga as an intervention.
Aim: To test the short-term effects of a validated yoga intervention as an adjunct to medication in patients with OCD.
Settings And Design: The study included patients diagnosed with OCD attending a tertiary psychiatry hospital in south India using a Randomized Controlled Trial (RCT) design.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!